keyword
https://read.qxmd.com/read/38652808/the-narrow-footprint-of-ancient-balancing-selection-revealed-by-heterokaryon-incompatibility-genes-in-aspergillus-fumigatus
#1
JOURNAL ARTICLE
Ben Auxier, Jianhua Zhang, Francisca Reyes Marquez, Kira Senden, Joost van den Heuvel, Duur K Aanen, Eveline Snelders, Alfons J M Debets
In fungi, fusion between individuals leads to localized cell death, a phenomenon termed heterokaryon incompatibility. Generally, the genes responsible for this incompatibility are observed to be under balancing selection resulting from negative frequency-dependent selection. Here, we assess this phenomenon in Aspergillus fumigatus, a human pathogenic fungus with a very low level of linkage disequilibrium as well as an extremely high crossover rate. Using complementation of auxotrophic mutations as an assay for hyphal compatibility, we screened sexual progeny for compatibility to identify genes involved in this process, called het genes...
April 23, 2024: Molecular Biology and Evolution
https://read.qxmd.com/read/38651897/the-traf3-dyrk1a-rad54l2-complex-maintains-ace2-expression-to-promote-sars-cov-2-infection
#2
JOURNAL ARTICLE
Dexin Mao, Shufeng Liu, An Thanh Phan, Stephanie Renner, Yan Sun, Tony T Wang, Yiping Zhu
UNLABELLED: Angiotensin converting enzyme 2 (ACE2), the host receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is differentially expressed in a wide variety of tissues and cell types. The expression of ACE2 is under tight regulation, but the mechanisms regulating ACE2 expression have not yet been well defined. Through a genome-wide CRISPR knockout screen, we discovered that host factors TRAF3, DYRK1A, and RAD54L2 (TDR) form a complex to regulate the expression of ACE2...
April 23, 2024: Journal of Virology
https://read.qxmd.com/read/38651250/differential-analysis-of-immunoglobulin-gene-expression-pattern-in-chickens-of-distinct-breeds-and-developmental-periods
#3
JOURNAL ARTICLE
Yanbo Qiu, Xiaohua Yi, Xiaoqin Tang, Yanpei Wei, Beibei Zhang, Shunan Duan, Shuhui Wang, Xiuzhu Sun
Immunoglobulin is an essential component of the body's defense against pathogens, aiding in the recognition and clearance of foreign antigens. Research concerning immunoglobulin gene and its diversity of expression across different breeds within the same species is relatively scarce. In this study, we employed RACE (Rapid Amplification of cDNA Ends) technology, prepared DNA libraries, performed high-throughput sequencing, and conducted related bioinformatics analysis to analyze the differences in immunoglobulin gene diversity and expression at different periods in Hy-line brown hens, Lueyang black-bone chickens, and Beijing-You chickens...
April 23, 2024: Journal of Animal Science
https://read.qxmd.com/read/38650031/nsabp-fb-10-a-phase-ib-ii-trial-evaluating-ado-trastuzumab-emtansine-t-dm1-with-neratinib-in-women-with-metastatic-her2-positive-breast-cancer
#4
JOURNAL ARTICLE
Samuel A Jacobs, Ying Wang, Jame Abraham, Huichen Feng, Alberto J Montero, Corey Lipchik, Melanie Finnigan, Rachel C Jankowitz, Mohamad A Salkeni, Sai K Maley, Shannon L Puhalla, Fanny Piette, Katie Quinn, Kyle Chang, Rebecca J Nagy, Carmen J Allegra, Kelly Vehec, Norman Wolmark, Peter C Lucas, Ashok Srinivasan, Katherine L Pogue-Geile
BACKGROUND: We previously reported our phase Ib trial, testing the safety, tolerability, and efficacy of T-DM1 + neratinib in HER2-positive metastatic breast cancer patients. Patients with ERBB2 amplification in ctDNA had deeper and more durable responses. This study extends these observations with in-depth analysis of molecular markers and mechanisms of resistance in additional patients. METHODS: Forty-nine HER2-positive patients (determined locally) who progressed on-treatment with trastuzumab + pertuzumab were enrolled in this phase Ib/II study...
April 22, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38647646/screening-and-surveillance-recommendations-for-central-nervous-system-hemangioblastomas-in-pediatric-patients-with-von-hippel-lindau-disease
#5
JOURNAL ARTICLE
Anna Laura Knoblauch, B-I Blaß, C Steiert, N Neidert, A Puzik, E Neumann-Haefelin, A Ganner, F Kotsis, T Schäfer, H P H Neumann, S Elsheikh, J Beck, J-H Klingler
PURPOSE: Von Hippel-Lindau (VHL) disease is an autosomal-dominantly inherited tumor predisposition syndrome. One of the most common tumors are central nervous system (CNS) hemangioblastomas. Recommendations on the initiation and continuation of the screening and surveillance program for CNS tumors in pediatric VHL patients are based on small case series and thus low evidence level. To derive more robust screening recommendations, we report on the largest monocentric pediatric cohort of VHL patients...
April 22, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38647526/a-nanopore-sequencing-based-pharmacogenomic-panel-to-personalize-tuberculosis-drug-dosing
#6
JOURNAL ARTICLE
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert J Wilkinson, Jason R Andrews
RATIONALE: Standardized dosing of anti-tubercular (TB) drugs leads to variable plasma drug levels, which are associated with adverse drug reactions, delayed treatment response, and relapse. Mutations in genes affecting drug metabolism explain considerable interindividual pharmacokinetic variability; however, pharmacogenomic (PGx) assays that predict metabolism of anti-TB drugs have been lacking. OBJECTIVES: To develop a Nanopore sequencing panel and validate its performance in active TB patients to personalize treatment dosing...
March 5, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38647181/motor-band-sign-is-specific-for-amyotrophic-lateral-sclerosis-and-corresponds-to-motor-symptoms
#7
JOURNAL ARTICLE
Charlotte Zejlon, Stefan Sennfält, Johannes Finnsson, Bryan Connolly, Sven Petersson, Tobias Granberg, Caroline Ingre
OBJECTIVE: Magnetic resonance imaging can detect neurodegenerative iron accumulation in the motor cortex, called the motor band sign. This study aims to evaluate its sensitivity/specificity and correlations to symptomatology, biomarkers, and clinical outcome in amyotrophic lateral sclerosis. METHODS: This prospective study consecutively enrolled 114 persons with amyotrophic lateral sclerosis and 79 mimics referred to Karolinska University Hospital, and also 31 healthy controls...
April 22, 2024: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/38644659/aop-report-development-of-an-adverse-outcome-pathway-for-deposition-of-energy-leading-to-cataracts
#8
JOURNAL ARTICLE
Emma Carrothers, Meghan Appleby, Vita Lai, Tatiana Kozbenko, Dalya Alomar, Benjamin J Smith, Nobuyuki Hamada, Patricia Hinton, Elizabeth A Ainsbury, Robyn Hocking, Carole Yauk, Ruth C Wilkins, Vinita Chauhan
Cataracts are one of the leading causes of blindness, with an estimated 95 million people affected worldwide. A hallmark of cataract development is lens opacification, typically associated not only with aging but also radiation exposure as encountered by interventional radiologists and astronauts during the long-term space mission. To better understand radiation-induced cataracts, the adverse outcome pathway (AOP) framework was used to structure and evaluate knowledge across biological levels of organization (e...
April 21, 2024: Environmental and Molecular Mutagenesis
https://read.qxmd.com/read/38642107/whole-brain-morphologic-features-improve-the-predictive-accuracy-of-idh-status-and-vegf-expression-levels-in-gliomas
#9
JOURNAL ARTICLE
Simin Zhang, Di Chen, Huaiqiang Sun, Graham J Kemp, Yinying Chen, Qiaoyue Tan, Yuan Yang, Qiyong Gong, Qiang Yue
Glioma is a systemic disease that can induce micro and macro alternations of whole brain. Isocitrate dehydrogenase and vascular endothelial growth factor are proven prognostic markers and antiangiogenic therapy targets in glioma. The aim of this study was to determine the ability of whole brain morphologic features and radiomics to predict isocitrate dehydrogenase status and vascular endothelial growth factor expression levels. This study recruited 80 glioma patients with isocitrate dehydrogenase wildtype and high vascular endothelial growth factor expression levels, and 102 patients with isocitrate dehydrogenase mutation and low vascular endothelial growth factor expression levels...
April 1, 2024: Cerebral Cortex
https://read.qxmd.com/read/38641551/clinical-mutations-in-the-tert-and-terc-genes-coding-for-telomerase-components-induced-oxidative-stress-dna-damage-at-telomeres-and-cell-apoptosis-besides-decreased-telomerase-activity
#10
JOURNAL ARTICLE
Beatriz Fernández-Varas, Cristina Manguan-García, Javier Rodriguez-Centeno, Lucía Mendoza-Lupiáñez, Joaquin Calatayud, Rosario Perona, Mercedes Martín-Martínez, Marta Gutierrez-Rodriguez, Carlos Benítez-Buelga, Leandro Sastre
Telomeres are nucleoprotein structures at the end of chromosomes that maintain their integrity. Mutations in genes coding for proteins involved in telomere protection and elongation produce diseases such as dyskeratosis congenita or idiopathic pulmonary fibrosis known as telomeropathies. These diseases are characterized by premature telomere shortening, increased DNA damage and oxidative stress. Genetic diagnosis of telomeropathy patients has identified mutations in the genes TERT and TERC coding for telomerase components but the functional consequences of many of these mutations still have to be experimentally demonstrated...
April 18, 2024: Human Molecular Genetics
https://read.qxmd.com/read/38641349/association-of-metabolomics-with-pd-1-inhibitor-plus-chemotherapy-outcomes-in-patients-with-advanced-non-small-cell-lung-cancer
#11
JOURNAL ARTICLE
Liang Zheng, Fang Hu, Lin Huang, Jun Lu, Xiaohua Yang, Jianlin Xu, Shuyuan Wang, Yinchen Shen, Runbo Zhong, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Hua Zhong, Wei Nie, Xueyan Zhang
BACKGROUND: Combining immune checkpoint inhibitors (ICIs) with chemotherapy has become a standard treatment for patients with non-small cell lung cancer (NSCLC) lacking driver gene mutations. Reliable biomarkers are essential for predicting treatment outcomes. Emerging evidence from various cancers suggests that early assessment of serum metabolites could serve as valuable biomarkers for predicting outcomes. This study aims to identify metabolites linked to treatment outcomes in patients with advanced NSCLC undergoing first-line or second-line therapy with programmed cell death 1 (PD-1) inhibitors plus chemotherapy...
April 18, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38641197/evidence-for-persistent-uv-induced-dna-damage-and-altered-dna-damage-response-in-xeroderma-pigmentosa-patient-corneas
#12
JOURNAL ARTICLE
Jacquelyn Akepogu, Saumya Jakati, Sunita Chaurasia, Charanya Ramachandran
Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by injury to the ocular surface due to exposure to ultraviolet (UV) radiation. UV-induced damage in the cells leads to the formation of cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine-pyrimidone photoproducts that are repaired by the NER (Nucleotide Excision Repair) pathway. Mutations in the genes coding for NER proteins, as reported in XP patients, would lead to sub-optimal damage repair resulting in clinical signs varying from photo-keratitis to cancerous lesions on the ocular surface...
April 17, 2024: Experimental Eye Research
https://read.qxmd.com/read/38640435/lysosomal-degradation-targets-mutant-calreticulin-and-the-thrombopoietin-receptor-in-myeloproliferative-neoplasms
#13
JOURNAL ARTICLE
Amanpreet Kaur, Arunkumar Venkatesan, Malathi Kandarpa, Moshe Talpaz, Malini Raghavan
Somatic mutants of calreticulin (CRT) drive myeloproliferative neoplasms (MPNs) via binding to the thrombopoietin receptor (MPL) and aberrant activation of the JAK/STAT pathway. Compared with healthy donors, platelets from MPN patients with CRT mutations display low cell surface MPL. Additionally, co-expression of MPL with an MPN-linked CRT mutant (CRTDel52) reduces cell surface MPL, suggesting that CRTDel52 may induce MPL degradation. We show that lysosomal degradation is relevant to the turnover of CRTDel52 and MPL...
April 19, 2024: Blood Advances
https://read.qxmd.com/read/38638626/a-novel-ornithine-aminotransferase-splice-site-mutation-causes-vitamin-b6-responsive-gyrate-atrophy
#14
Samira Molaei Ramshe, Safoura Zardadi, Elham Alehabib, Ramin Nourinia, Javad Jamshidi, Mohsen Soosanabadi, Hossein Darvish
PURPOSE: Gyrate atrophy of the choroid and retina (GACR) is a rare congenital disorder and mutations in the ornithine aminotransferase (OAT) gene has been specified as the underlying cause. Patients show a high level of ornithine in body fluids which may be controlled by low protein diets. Pyridoxine (vitamin B6) supplementation may also be effective, however, most patients appear to be nonresponsive to this modality of treatment. CASE REPORT: Here, we report a characterized case of a vitamin B6-responsive GACR who had a splicing mutation in the OAT gene...
2024: Journal of Ophthalmic & Vision Research
https://read.qxmd.com/read/38637813/alkbh5-modulates-macrophages-polarization-in-tumor-microenvironment-of-ovarian-cancer
#15
JOURNAL ARTICLE
Yuanyuan An, Hua Duan
BACKGROUND: Macrophages play an essential role in regulating ovarian cancer immune microenvironment. Studies have shown that m6A methylation could influence immune microenvironment in cancer. In this study, we investigated the roles of m6A demethylase ALKBH5 and m6A recognition protein IGF2BP2 played in regulating macrophages polarization in ovarian cancer. METHODS: In this study, we first explored the differentially expressed m6A methylation enzymes in M0 and M2 macrophages according to two independent GEO datasets...
April 18, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38637440/identifying-diffuse-glioma-subtypes-based-on-pathway-enrichment-evaluation
#16
JOURNAL ARTICLE
Qiushi Feng, Zehua Dong, Rongfang Nie, Xiaosheng Wang
Gliomas are highly heterogeneous in molecular, histology, and microenvironment. However, a classification of gliomas by integrating different tumor microenvironment (TME) components remains unexplored. Based on the enrichment scores of 17 pathways involved in immune, stromal, DNA repair, and nervous system signatures in diffuse gliomas, we performed consensus clustering to uncover novel subtypes of gliomas. Consistently in three glioma datasets (TCGA-glioma, CGGA325, and CGGA301), we identified three subtypes: Stromal-enriched (Str-G), Nerve-enriched (Ner-G), and mixed (Mix-G)...
April 18, 2024: Interdisciplinary Sciences, Computational Life Sciences
https://read.qxmd.com/read/38635934/randomized-phase-ii-study-of-gemcitabine-with-or-without-atr-inhibitor-berzosertib-in-platinum-resistant-ovarian-cancer-final-overall-survival-and-biomarker-analyses
#17
JOURNAL ARTICLE
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre André B A da Costa, Doga Gulhan, Andrea E Wahner Hendrickson, Bose Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D D'Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulonis
PURPOSE: The multicenter, open-label, randomized phase 2 NCI-9944 study (NCT02595892) demonstrated that addition of ATR inhibitor (ATRi) berzosertib to gemcitabine increased progression-free survival (PFS) compared to gemcitabine alone (hazard ratio [HR]=0.57, one-sided log-rank P = .044, which met the one-sided significance level of 0.1 used for sample size calculation). METHODS: We report here the final overall survival (OS) analysis and biomarker correlations (ATM expression by immunohistochemistry, mutational signature 3 and a genomic biomarker of replication stress) along with post-hoc exploratory analyses to adjust for crossover from gemcitabine to gemcitabine/berzosertib...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38635528/integration-of-single-cell-rna-seq-and-bulk-rna-seq-to-construct-liver-hepatocellular-carcinoma-stem-cell-signatures-to-explore-their-impact-on-patient-prognosis-and-treatment
#18
JOURNAL ARTICLE
Lixia Liu, Meng Zhang, Naipeng Cui, Wenwen Liu, Guixin Di, Yanan Wang, Xin Xi, Hao Li, Zhou Shen, Miaomiao Gu, Zichao Wang, Shan Jiang, Bin Liu
BACKGROUND: Liver hepatocellular carcinoma (LIHC) is a prevalent form of primary liver cancer. Research has demonstrated the contribution of tumor stem cells in facilitating tumor recurrence, metastasis, and treatment resistance. Despite this, there remains a lack of established cancer stem cells (CSCs)-associated genes signatures for effectively predicting the prognosis and guiding the treatment strategies for patients diagnosed with LIHC. METHODS: The single-cell RNA sequencing (scRNA-seq) and bulk RNA transcriptome data were obtained based on public datasets and computerized firstly using CytoTRACE package and One Class Linear Regression (OCLR) algorithm to evaluate stemness level, respectively...
2024: PloS One
https://read.qxmd.com/read/38633264/-nlrp2-deletion-ameliorates-kidney-damage-in-a-mouse-model-of-cystinosis
#19
JOURNAL ARTICLE
Marianna Nicoletta Rossi, Valentina Matteo, Francesca Diomedi-Camassei, Ester De Leo, Olivier Devuyst, Mohamed Lamkanfi, Ivan Caiello, Elena Loricchio, Francesco Bellomo, Anna Taranta, Francesco Emma, Fabrizio De Benedetti, Giusi Prencipe
Cystinosis is a rare autosomal recessive disorder caused by mutations in the CTNS gene that encodes cystinosin, a ubiquitous lysosomal cystine/H+ antiporter. The hallmark of the disease is progressive accumulation of cystine and cystine crystals in virtually all tissues. At the kidney level, human cystinosis is characterized by the development of renal Fanconi syndrome and progressive glomerular and interstitial damage leading to end-stage kidney disease in the second or third decade of life. The exact molecular mechanisms involved in the pathogenesis of renal disease in cystinosis are incompletely elucidated...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38631667/recent-advancements-in-nanomaterial-mediated-ferroptosis-induced-cancer-therapy-importance-of-molecular-dynamics-and-novel-strategies
#20
REVIEW
Namdev Dhas, Ritu Kudarha, Ruchi Tiwari, Gaurav Tiwari, Neha Garg, Praveen Kumar, Sanjay Kulkarni, Jahnavi Kulkarni, Soji Soman, Aswathi R Hegde, Jayvadan Patel, Atul Garkal, Anam Sami, Deepanjan Datta, Viola Colaco, Tejal Mehta, Lalitkumar Vora, Srinivas Mutalik
Ferroptosis is a novel type of controlled cell death resulting from an imbalance between oxidative harm and protective mechanisms, demonstrating significant potential in combating cancer. It differs from other forms of cell death, such as apoptosis and necrosis. Molecular therapeutics have hard time playing the long-acting role of ferroptosis induction due to their limited water solubility, low cell targeting capacity, and quick metabolism in vivo. To this end, small molecule inducers based on biological factors have long been used as strategy to induce cell death...
April 15, 2024: Life Sciences
keyword
keyword
95504
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.